Literature DB >> 10547361

Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system.

A D Rogove1, C Siao, B Keyt, S Strickland, S E Tsirka.   

Abstract

Tissue plasminogen activator mediates excitotoxin-induced neurodegeneration and microglial activation in the mouse hippocampus. Here we show that tissue plasminogen activator (tPA) acts in a protease-independent manner to modulate the activation of microglia, the cells of the central nervous system with macrophage properties. Cultured microglia from tPA-deficient mice can phagocytose as efficiently as wild-type microglia. However, tPA-deficient microglia in mixed cortical cultures exhibit attenuated activation in response to lipopolysaccharide, as judged by morphological changes, increased expression of the activation marker F4/80 and the release of the pro-inflammatory cytokine tumor necrosis factor-(&agr;). When tPA is added to tPA deficient cortical cultures prior to endotoxin stimulation, microglial activation is restored to levels comparable to that observed in wild-type cells. Proteolytically-inactive tPA can also restore activation of tPA-deficient microglia in culture and in vivo. However, this inactive enzyme does not restore susceptibility of tPA-deficient hippocampal neurons to excitotoxin-mediated cell death. These results dissociate two different functions of tPA: inactive enzyme can mediate microglial activation, whereas proteolytically-competent protein also promotes neuronal degeneration. Thus tPA is identified as a new cytokine in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547361     DOI: 10.1242/jcs.112.22.4007

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  42 in total

1.  Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.

Authors:  Amjad Shehadah; Jieli Chen; Xu Cui; Cynthia Roberts; Mei Lu; Michael Chopp
Journal:  J Neurol Sci       Date:  2010-05-07       Impact factor: 3.181

Review 2.  Tissue plasminogen activator and seizures: a clot-buster's secret life.

Authors:  Robert Pawlak; Sidney Strickland
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 3.  Microglial functions and proteases.

Authors:  Hiroshi Nakanishi
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

4.  Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.

Authors:  William M Armstead; John Riley; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

Review 5.  Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

7.  Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis.

Authors:  Weiquan Lu; Madhuri Bhasin; Stella E Tsirka
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

8.  The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

Authors:  Chen Zhang; Jie An; Dudley K Strickland; Manuel Yepes
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  uPA modulates the age-dependent effect of brain injury on cerebral hemodynamics through LRP and ERK MAPK.

Authors:  William M Armstead; Douglas B Cines; Khalil H Bdeir; Yasmina Bdeir; Sherman C Stein; Abd Al-Roof Higazi
Journal:  J Cereb Blood Flow Metab       Date:  2008-12-03       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.